Click to enlarge. Source: Express Scripts. H/t: Michael Ramlet. (There will not be a TIE chart of the day every day.)
Masthead
Editors in Chief
Austin Frakt
Aaron Carroll
Managing Editor
Adrianna McIntyre
Contributors
Kevin Outterson
Bill Gardner
Nicholas Bagley
Other ContributorsRecent posts
- What can we expect from re-opening HealthCare.gov? Hope.
- The Rising Crisis of Underinsurance: How the Biden Administration May Shape Inequities in Patient Affordability
- How Genomics Improve Cancer Survival and Patient Quality of Life: The Healthcare Triage Podcast
- The End of Surprise Billing for Medical Care?
- Drug Prices by Committee: One Way Biden Could Lower Costs
- Recent publications from Boston University’s Department of Health Law, Policy and Management: February 2021 Edition
- Out-of-network payments in Medicare Advantage
- Cancer Journal: What is health?
- Should You Worry About Covid Vaccine Side Effects?
- U.S. should prepare for a COVID-19 hospital consolidation surge
Archives
For speaking inquiries
Interested in having Aaron or Austin speak to your group?
For information on Aaron speaking, click here.
For information on Austin speaking, contact the Leigh Bureau.
Aaron’s stuff
Selected appearances:
The Colbert Report
Good Morning America
Sound Medicine (most recent)
The Ed ShowAustin’s stuff
Click here for links to Austin’s peer-reviewed publications and/or related posts.
Chart of the day: brand vs. generic drug price growth
11/29/2012
Austin Frakt
item.php
Follow the blog
TIE Books
Amazon.com
Barnes & Noble
Indiebound
iBooks
Google
Kobo
Amazon.com
Barnes & Noble
Books-A-Million
iBooks
IndieBound
Powells
Buy at Amazon.com
Summary
Excerpt: Economic profit
Excerpt: Diminishing marginal utility
Excerpt: Four factors of production
Excerpt: Monopoly marginal revenue
Excerpt: Consumer/producer surplus
Amazon.com
Barnes & Noble
Books-A-Million
Borders
IndieBound
Powells
Borders
Barnes & Noble
IndieBound
Amazon.com
Books-A-Million
Powells
Austin and Aaron are participants in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.Tag cloud
ACA AcademyHealth access accountable care organizations Affordable Care Act announcement blogging cancer comic competitive bidding costs cost shifting COVID-19 employer-sponsored health insurance health care costs Healthcare Triage health insurance health insurance mandates health reform hospital readmissions hospitals individual mandate insurance exchange market power Massachusetts Medicaid Medicare Medicare Advantage mortality nutrition obesity On The Record physicians politics PPACA premiums prescription drugs quality reading list reflex RWJF spending uninsured Upshot vaccines
by steve on November 29th, 2012 at 21:40
And this is w/o any new blockbusters coming out for the most part.
Steve
by David J. Littleboy on November 30th, 2012 at 03:23
FWIW, and as you might expect, Japan is very aggressive about switching to generics as soon as they are available. And is very upfront about telling the patient; the pharmacy that fills my prescription is appologetic about charging me (my 30%; insurance covers the other 70%) for non-generics, explaining that they’ve switched to a generic of this but that a a generic version of that isn’t out yet. (I mention this because I understand that there’s some fine print in Medicare that prevents a switch to generics in some cases.)
by Scott Supak on December 4th, 2012 at 17:19
I just sent this to Dean Baker. I hope his head doesn’t explode.
The fact that the people who missed the largest asset bubble in history are now paid to tell us that extended patent protections are a good thing is a tragedy, It’s certainly not “free markets” or a meritocracy.
by Saumil on December 17th, 2012 at 09:13
Woha , A miracle medicine is one which is of same price as it was last year, and look at generics medicine they are cheaper then what they were last year!!!!